Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SEMAGLUTIDE Cause Product use issue? 932 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 932 reports of Product use issue have been filed in association with SEMAGLUTIDE (WEGOVY). This represents 1.6% of all adverse event reports for SEMAGLUTIDE.

932
Reports of Product use issue with SEMAGLUTIDE
1.6%
of all SEMAGLUTIDE reports
3
Deaths
218
Hospitalizations

How Dangerous Is Product use issue From SEMAGLUTIDE?

Of the 932 reports, 3 (0.3%) resulted in death, 218 (23.4%) required hospitalization, and 9 (1.0%) were considered life-threatening.

Is Product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SEMAGLUTIDE. However, 932 reports have been filed with the FAERS database.

What Other Side Effects Does SEMAGLUTIDE Cause?

Nausea (10,036) Vomiting (6,518) Off label use (5,425) Diarrhoea (5,331) Decreased appetite (4,317) Constipation (4,036) Weight decreased (3,518) Impaired gastric emptying (2,622) Product use in unapproved indication (2,613) Wrong technique in product usage process (2,538)

What Other Drugs Cause Product use issue?

INFLIXIMAB (12,752) DUPILUMAB (10,575) POLYETHYLENE GLYCOL 3350 (9,432) METHOTREXATE (8,185) DICLOFENAC (8,009) RITUXIMAB (6,948) ADALIMUMAB (6,379) ETANERCEPT (6,062) TOCILIZUMAB (5,944) ABATACEPT (5,915)

Which SEMAGLUTIDE Alternatives Have Lower Product use issue Risk?

SEMAGLUTIDE vs SEMUSTINE SEMAGLUTIDE vs SENNA LEAF SEMAGLUTIDE vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B SEMAGLUTIDE vs SENNOSIDES SEMAGLUTIDE vs SENNOSIDES A AND B

Related Pages

SEMAGLUTIDE Full Profile All Product use issue Reports All Drugs Causing Product use issue SEMAGLUTIDE Demographics